Epstein-Barr virus provides a survival factor to Burkitt's lymphomas
AUTOR(ES)
Kennedy, Gregory
FONTE
National Academy of Sciences
RESUMO
Epstein-Barr virus (EBV) has been causally associated with at least five human malignancies. The exact contributions made by EBV to these cancers remain unknown. We demonstrate that one viral protein found in all EBV-associated malignancies, Epstein-Barr nuclear antigen 1 (EBNA-1), is required for survival of one of these cancers, EBV-positive Burkitt's lymphoma. Inhibition of EBNA-1 decreases survival of these tumor cells by inducing apoptosis. Expression of EBNA-1 in uninfected cells also can inhibit apoptosis induced by expression of p53 in the absence of the EBV genome. Our findings demonstrate that EBNA-1 is critical for the continued survival of EBV-associated Burkitt's lymphoma, and, by extension, for the other B cell tumors with which EBV is associated. Efficient inhibitors of EBNA-1's functions would likely prove useful in the therapy of EBV-associated malignancies.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=283581Documentos Relacionados
- Epstein-Barr Virus-Associated Membrane-Reactive Antibodies During Long Term Survival After Burkitt's Lymphoma
- Epstein–Barr virus RNA confers resistance to interferon-α-induced apoptosis in Burkitt’s lymphoma
- Antibodies to Epstein-Barr Virus in a Burkitt's Lymphoma Cell Line in Taiwan Monkeys (Macaca cyclopis)
- Epstein–Barr virus and Burkitt lymphoma
- Epstein–Barr virus-encoded poly(A)– RNA supports Burkitt’s lymphoma growth through interleukin-10 induction
